, and IL-25 and are important for IgE production, eosinophilic inflammation, and the clearance of helminthic parasite infections. 2 In light of recent data, the T H 1/T H 2 dichotomy is now being revisited. The discovery of the IL-17 family of cytokines and the analysis of IL-23-mediated effector functions on T cells have suggested the existence of an additional subset of CD4 1 T cells that produce IL-17 and for this reason were designated T H 17 cells. [3] [4] [5] [6] The independence of the T H 17 subset with regard to T H 1 and T H 2 cells was firmly established with the identification of specific cytokines and transcription factors required for lineage differentiation ie the combination of IL-6 and TGF-b [7] [8] [9] and the transcription factors retinoic acid-related orphan receptor g (RORgt) 10 and signal transducer and activator of transcription (STAT) 3. 11, 12 T H 17 effector functions are distinct from T H 1-and T H 2-mediated immunity. T H 17 cells appear to be critical for enhancement of host protection against extracellular bacteria and fungi, which are not efficiently cleared by T H 1 and T H 2 responses. In addition, T H 17 cells have emerged as potent mediators of autoimmune disease.
Including the regulatory T (Treg) cell subset, 13 there are now 4 functionally unique populations of CD4 1 T cells that are directly involved in the regulation of immune responses to pathogens, allergens, and self-antigens. Any molecular defect involving either the entire CD4
1 T-cell population, such as severe combined Immunodeficiency, or individual subsets, such as lack of Treg cells 14 or IL-17 cells, 15 might result in human disease (Table I ). In this review we explore the biology of T H 17 and Treg cells and their roles in human primary immune deficiency diseases.
DIFFERENTIATION AND FUNCTION OF T H 17 CELLS
Since their discovery, T H 17 cells have been recognized as a unique effector T-cell subset capable of producing IL-17, a cytokine originally cloned in 1995. 16 IL-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines 17 and initiates the recruitment of neutrophils, linking adaptive and innate immunity. 18 Initial studies of T H 17 cell biology performed in mice focused on identifying key factors required for the differentiation and function of T H 17 cells. Early investigations of T H 17 cell development in human subjects suggested that it might differ from that observed in the mouse [19] [20] [21] ; more recent reports, however, suggest that major events controlling T H 17 cell development are similar in both species. [22] [23] [24] To become T H 17 cells, naive murine CD4 1 T cells have to be activated through the T-cell receptor in the presence of TGF-b and IL-6, which leads to the expression of the transcription factor RORgt. 10 Just as IFN-g, IL-12, and T-box transcription factor (T-bet) control T H 1 development and IL-4 and GATA3 control T H 2 development, TGF-b, IL-6, and RORgt drive naive CD4 1 T cells toward the T H 17 lineage, at least in part, by directly inducing the expression of IL-17. 25 The effects of IL-6 on T H 17 cell differentiation are mediated by the transcription factor STAT3, which is required for RORgt expression (Table I) . 11, 12, 26 In patients with autosomal dominant hyper-IgE syndrome (AD-HIES) caused by heterozygous STAT3 mutations that cause the generation of nonfunctional STAT3, RORgt expression and T H 17 cell development is severely impaired. 15, 27 In human effector T-cell differentiation, TGF-b and IL-6 are important in the generation of T H 17 cells, but IL-1b also appears to play a prominent role in the induction of RORgt. This is further enhanced by IL-23. 19, 20 In mice IL-23 seems to play a role only in activated T cells that express the IL-23 receptor and therefore might induce T H 17 differentiation in memory, but not in naive, T cells, 28 suggesting that IL-23 upregulates IL-17 production and promotes survival and expansion of activated memory T H 17 cells. If this assumption is correct, IL-23 must be crucial for the maintenance of autoimmune inflammation. 4, 29 A recent in-depth analysis has concluded that TGF-b, IL-23, and the proinflammatory cytokines IL-1b and IL-6 are, in fact, essential mediators of human T H 17 cell differentiation and are required for the expression of IL-17, IL-23 receptor, and RORgt. 23 These observations were confirmed by the Littman laboratory, which reported that human cord blood CD4
1 T cells, naive by definition, differentiate into T H 17 cells only if TGF-b, IL-1b, IL-6, and IL-23 or IL-21 are present and that this process requires the expression of RORgt but not T-bet or GATA3. 22 These studies demonstrate that TGF-b and IL-6 are important for T H 17 development in both human subjects and mice, whereas IL-1b and IL-23 play a more important role in human subjects than mice.
CYTOKINE PRODUCTION BY T H 17 CELLS
The T H 17 signature cytokines IL-17 (IL-17A) and IL-17F are closely related and form biologic active homodimers or heterodimers. By interacting with its receptor, IL-17 initiates nuclear factor kB activation, which leads to the transcription of multiple target genes involved in innate immunity. These include chemokines, such as CXCL8 (IL-8) and CCL20; the cytokines IL-6, TNF-a, granulocyte colony-stimulating factor (G-CSF), and GM-CSF; acute-phase proteins, such as C-reactive protein; and antimicrobial peptides and mucins. 30 Thus IL-17 plays an important role in antimicrobial defenses by recruiting and expanding the neutrophil lineage and producing antimicrobial factors. In addition, antibody responses to T-dependent antigens are defective in IL-17-deficient mice 31 and in patients with AD-HIES who lack T H 17 cells. 32 In addition to IL-17, activated murine T H 17 cells produce IL-21, which appears to play an important autocrine role in maintaining T H 17 cell differentiation, similar to the autocrine function of IFN-g in the generation of T H 1 cells and IL-4 in promoting T H 2 cells (Table I and Fig 1) . In mice IL-21 expression is under the control of STAT3, which binds to the IL-21 promoter in T H 17 cells. Although IL-21 production is RORgt independent, IL-21 itself helps to sustain expression of RORgt and IL-17 and induces IL-23 receptor expression. [33] [34] [35] A role for IL-21 in the differentiation of human T H 17 cells is less clear, although it is likely based on the observation that IL-21 upregulates IL-17 production and downregulates Treg cell function. 36, 37 Other proinflammatory cytokines produced by human and murine T H 17 cells include TNF-a, IL-22, and IL-26, which are involved in innate immunity, and IL-6, which directs CD4 1 T-cell differentiation toward the T H 17 lineage, as discussed above. 38 IL-22 has been associated with the generation of defensins, acute-phase proteins, and inflammatory cytokines. 30, 39 Some subsets of T H 17 cells can coexpress IL-17 and IFN-g 19 or IL-17 and IL-10, 40 respectively; however, the function of these double-positive T cells remains to be determined. It has been suggested, based on mouse models, that T H 17 cells are not as stable as T H 1 or T H 2 cells and that in the presence of IL-12, T H 17 cells might revert to T H 1-like cells. 41 
TRAFFICKING OF T H 17 CELLS
To be effective, the adaptive immune system has the fundamental task of facilitating the encounter of antigen-specific T and B lymphocytes with exogenous antigens and with one another. Exogenous antigens are picked up, processed, and presented by antigen-presenting cells in specialized microenvironments within secondary lymphoid organs, skin, and mucous membranes. CCR7, expressed by mature dendritic cells and T cells, including Treg cells, and its ligands CCL19 and CCL21 play a major role in the homing of dendritic cells and naive T cells to secondary lymphoid organs, where antigen presentation and effector T-cell differentiation takes place. 42 Both human and murine T H 17 cells express CCR6, 43, 44 although not all CCR6 1 cells are T H 17 cells. Coexpression of CCR4 with CCR6 appears to correlate with a classic T H 17 cell phenotype, including RORgt expression and IL-17 production. 43 Interestingly, CCR6 induces homing of cells to skin and mucosal sites and plays a causative role in many inflammatory diseases considered to be initiated and/or maintained by IL-17, including psoriasis, ulcerative colitis, asthma, and rheumatoid arthritis. The CCR6 ligand CCL20 is expressed by T H 17 cells and is upregulated in stromal cells by IL-17, allowing the attraction of additional T H 17 cells into inflamed tissue. 44 
FORKHEAD BOX PROTEIN 3-POSITIVE TREG CELLS

Whereas naive murine CD4
1 T cells differentiate into T H 17 cells if cocultured with TGF-b and IL-6, as described above, exposure to TGF-b and IL-2 causes differentiation into a Treg cell phenotype, including forkhead box protein 3 (Foxp3) expression and suppressive function. 8 Furthermore, addition of retinoic acid to the culture enforces the generation of Treg cells and inhibits the differentiation of T H 17 cells. 45 Treg cells play a critical role in the maintenance of selftolerance by suppressing, in a dominant manner, immune activation of self-aggressive T effector cells. 13 Upregulation of Treg cell function or increases in the numbers of cells might be beneficial for treating autoimmune diseases and allergies and for preventing allograft rejection. Conversely, inhibiting Treg cell function or decreasing Treg cell numbers might boost immunity against tumors and microorganisms.
Treg cells are characterized by the expression of the transcription factor FOXP3, [46] [47] [48] which is induced by TGF-b in the presence of IL-2 (Table I and Fig 1) . 49 Absence of FOXP3 in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome 14 or scurfy mice 50 results in lack of functional Treg cells. Overexpression of FOXP3 in conventional T cells directs them to a Treg cell phenotype with suppressive activity, leading to a state of immune deficiency. 46, 51 The majority of Treg cells express high levels of CD25 (IL-2 receptor a), 13 suggesting a major influence of IL-2 for the long-term maintenance and competitiveness of these cells. STAT5, which is activated by IL-2, has been shown to be required for the maintenance of FOXP3 expression through binding to its promoter. 52, 53 Treg cells also express TGF-b, IL-10, cytotoxic T lymphocyte-associated antigen 4 (CTLA4), and glucocorticoid-induced TNF receptor (GITR), which might play a role in their function.
Treg cells can either differentiate in the thymus and emigrate into the periphery as fully functional natural suppressor cells, or they can be induced in the periphery from naive T-cell precursors. The differentiation of Treg cells from naive CD4 T cells occurs when exposed to TGF-b and IL-2. 8 It has recently been demonstrated in mice that Treg cell-derived TGF-b can generate de novo CD4 1 Foxp3 1 T cells in vitro from naive precursor T cells. 54 Homing of Treg cells to sites of inflammation is required for their suppressive function. Schneider et al 55 recently demonstrated that in CCR7 knockout mice, CD4
1
CD25
1 Foxp3 1 Treg cells were unable to home to lymph nodes and were unable to suppress antigen-induced T-cell responses. When compared with wild-type Treg cells, the CCR7-deficient Treg cells were less effective in preventing the development of inflammatory bowel disease when transferred into a severe combined immunodeficiency mouse model. The importance of cutaneous Treg cells for the maintenance of immune homeostasis in the skin has been elegantly demonstrated in transfer experiments using Foxp3-deficient scurfy mice. Neonatal scurfy mice were injected with functional Treg cells that were manipulated to no longer be able to migrate to the skin by inducing a targeted mutation of the gene encoding a-1, 3-fucosyltransferase VII (FuT7). This enzyme is required for the generation of the carbohydrate determinants of the E-and P-selectin ligands, which are required for optimal migration of T cells to the skin. FuT7-deficient Treg cells restored the Treg cell compartment, except for the skin. Loss of FuT7 selectively reduced Treg cell accumulation in the skin and resulted in severe cutaneous inflammation without other scurfyassociated symptoms. 56 
T H 17 CELLS IN PRIMARY IMMUNODEFICIENCY DISEASES
As described above, differentiation of murine T H 17 cells from naive CD4
1 T cells depends on IL-6 and TGF-b signaling and the activation of STAT3. This was confirmed by the observation that CD4
1 T cells conditionally deficient in STAT3 demonstrated impaired differentiation into T H 17 cells and showed reduced production of IL-17.
11, 26 The recent identification of heterozygous STAT3 defects as the molecular cause of AD-HIES raised the interesting possibility that patients with this disorder might have defective T H 17 cell development, function, or both. In addition, the observations that patients with AD-HIES/Job syndrome are uniquely susceptible to Candida species infections, 57, 58 that Candida species-specific human memory T cells are predominantly present in the T H 17 cell subset, 43 and that IL-17-and IL-17 receptor-deficient mice had substantially reduced survival compared with that seen in control mice when challenged with Candida albicans 59 led to a systematic assessment of T H 17 cells in patients with AD-HIES. 15 ,27,60,61 AD-HIES is an autosomal dominant primary immune deficiency disorder characterized by eczema, Staphylococcus aureus skin abscesses, pneumonia with pneumatocele formation, Candida species infections, and skeletal and connective tissue abnormalities. 58 Immunologic defects reported include markedly increased serum IgE levels, eosinophilia, a neutrophil chemotactic defect, 62 abnormal cytokine production, 63 and abnormal antibody responses to bacteriophage FX174. 32 As a result, patients with AD-HIES have abnormal susceptibility to a narrow spectrum of infections, including S aureus and C albicans.
Flow cytometric analysis of peripheral blood lymphocytes and CD4 1 T cells from patients with AD-HIES and healthy control subjects showed a comparable distribution of naive and memory T cells. However, the proportion of circulating T H 17 cells was noted to be markedly diminished. 15, 27, 60, 61 Circulating CD4
1
T cells from healthy control subjects, if activated with anti-CD3/anti-CD28 mAb, secreted abundant amounts of IL-17 and IL-22; in contrast, cells from patients with AD-HIES did not secrete either of these lymphokines, demonstrating that in human subjects production of both IL-17 and IL-22 by activated T cells is dependent on functional STAT3. 27 Furthermore, purified naive T cells from patients with AD-HIES were unable to differentiate in vitro to T H 17 cells when submitted to T-cell receptor activation (anti-CD3/anti-CD28) in the presence of a cocktail of cytokines (IL-1b, IL-6, and IL-23). 15, 27 Interestingly, the expression of RORgt mRNA was also markedly impaired in AD-HIES cells cultured under these conditions, 15, 27 which is in agreement with the hypothesis that impaired STAT3 function interferes with the expression of RORgt, which is required for T H 17 cell differentiation.
To test the effect of other cytokines that govern the differentiation of T H 17 cells in humans, de Beaucoudrey et al 60 studied T H 17 cell development in patients with mutations in the IL-1 receptor-associated kinase 4 gene (IRAK4) or myeloid differentiation primary response gene 88 (MYD88), the cells of which do not respond to IL-1b, and in patients with mutations in the IL-12 p40 subunit gene (IL12B) or IL-12 p40 subunit receptor 1 gene (IL12RB1), the cells of which do not express or do not respond to IL-12 or IL-23. Results of these in vitro studies demonstrated that mutations in IRAK4/MYD88 had no detectable effect on T H 17 cell generation but that mutations in IL12B and IL12RB1 led to impaired generation of IL-17-producing cells, although 1 T-cell subsets generates a unique set of cytokines that control their biologic functions. Shaded boxes below each subset indicate key transcription factors involved in the development and maintenance of each subset. Green, Cytokines that promote development of each particular subset. Red, Cytokines that prevent the development of each particular subset. LTa, Lymphotoxin a; RA, retinoic acid. less pronounced than seen in patients with heterozygous STAT3 mutations. These observations suggest that IL-12 and IL-23 are important for T H 17 cell differentiation in human subjects but that T cells that are hyporesponsive to IL-1b can still be driven into the T H 17 lineage (Table I) .
FOXP3
TREG CELLS IN PRIMARY IMMUNODEFICIENCY DISEASES
Mutations in the FOXP3 transcription factor result in IPEX syndrome (Table I ). The majority of affected individuals lack circulating and tissue-associated FOXP3
1 Treg cells and have multiple autoimmune disorders affecting the gut, skin, endocrine organs, blood cells, and joints. Death typically occurs in early childhood unless treated with aggressive immunosuppression, hematopoietic stem cell transplantation, or both.
14 The scurfy mouse, characterized by lymphocytic infiltrates in multiple organs and early death as a result of Treg cell deficiency, 50 has a naturally occurring mutation of Foxp3: a 2-bp insertion upstream of the forkhead domain, resulting in a frame shift and loss of the DNA-binding domain. 64 A clinical syndrome resembling IPEX syndrome is associated with mutations in the a-chain of the IL-2 receptor (CD25). Patients lacking CD25 present with an IPEX-like phenotype; in addition, they have infectious complications resembling those observed in patients with T-cell deficiency, such as recurrent cytomegalovirus-induced pneumonitis, Candida species infections, and chronic gastrointestinal disease. 65, 66 CD25-deficient mice have a phenotype similar to that of scurfy mice. 67 Although Treg cell development in the thymus and in vitro suppressive function of CD4 1 Foxp3 1 T cells are normal, these mice have a defect in survival, maintenance, and competitive fitness of mature Treg cells. 68, 69 Mutations of STAT5b, a key mediator of IL-2-induced gene transcription, cause a rare recessive disorder characterized by dwarfism (Laron dwarfs) and low serum concentrations of insulin-like growth factor 1 (but normal serum growth hormone levels). [70] [71] [72] Other physical features include a prominent forehead, a saddle nose, and a high pitched voice. Most patients have a marked immune deficiency characterized by recurrent varicella and herpes virus infections and Pneumocystis jiroveciinduced pneumonia, suggesting defective T-cell and natural killer cell function. 71, 72 In addition, most patients with STAT5b mutations present with diarrhea, eczema, and lymphocytic interstitial pneumonitis, suggesting immune dysregulation. [70] [71] [72] Patients studied for Treg cell pathology showed fewer CD4 Autoimmune polyendocrinopathy, candidiasis, and ectodermal dystrophy (APECED) syndrome is an autosomal recessive disorder characterized primarily by hypoparathyroidism, adrenal insufficiency, and chronic mucocutaneous candidiasis. Type 1 diabetes, gonadal failure, and pernicious anemia also occur but are less frequent. APECED syndrome is caused by mutations in the autoimmune regulator gene (AIRE), a transcription factor responsible for the ectopic expression of tissue-specific antigens on thymic medullary epithelial cells. As a consequence, AIRE is essential for the negative selection of autoreactive T-cell clones. 73, 74 Lymphocytes from patients with APECED syndrome were evaluated by means of flow cytometry and quantitative realtime PCR to address the possibility of AIRE playing a role in the generation of functional Treg cells. Consistently, the percentages of CD4
1
CD24
high cells were decreased, the amount of FOXP3 expressed per cell was diminished, and the ability to suppress effector T cells was reduced. 75 The Wiskott-Aldrich syndrome (WAS) is a rare X-linked disorder caused by mutations in the gene encoding WAS protein (WASP). 76 In addition to thrombocytopenia, small platelets, eczema, recurrent infections caused by cellular immunodeficiency, and malignancies, approximately 40% to 70% of the patients with classic WAS experience autoimmune diseases. 77, 78 In mice WasP does not play a role in thymic Treg cell production but is required for peripheral Treg cell expansion and survival and for effective suppressive function. [79] [80] [81] Although WASP deficiency in human subjects is not associated with a decrease in the percentage of Treg cells in the peripheral blood, Treg cell function was found to be consistently reduced, as demonstrated by the inability to suppress proliferation of effector T cells. 81 
CONCLUSION
Recent advances made in our understanding of the role of T-cell subsets in the regulation of immune responses against infectious agents and self-antigens have provided new insight into human immunopathology. The discovery that specific cytokines and unique transcriptional regulators control the differentiation of distinct T-cell subsets have expanded and refined the aging T H 1/T H 2 paradigm. New lineage-specific cytokines have been discovered, and their role in the activation of transcription factors, such as T-bet, GATA3, RORgt, and FOXP3, have been explored. Together with members of the STAT family of transcriptional regulators, these DNA-binding proteins direct the differentiation of naive CD4 1 T cells into T H 1, T H 2, T H 17, and Treg cells and induce the expression of signature cytokines unique for each T-cell lineage. This impressive progress was made possible by the development of novel biotechnologies that facilitate the study of gene regulation, protein expression, and cell differentiation and by the creation of unique genetically engineered mouse models. These innovative experimental strategies were complemented by careful observation of patients with unique congenital syndromes characterized by immune dysfunction, severe infections, autoimmune diseases, and allergic complications. The beneficiaries of these efforts (as of February 2009, there are 60,000 hits on PubMed when searching for T H 1, T H 2, T H 17, and Treg cells) are the clinical immunologists who have at their disposal new diagnostic techniques, more therapeutic options based on scientific medicine, and the hard facts required for authoritative genetic counseling of these complex patients. It is likely that these advances will lead to entirely new treatment strategies for severe infections, allograft rejection, cancer, and autoimmune and allergic diseases. 
